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Executive Summary 
 
 
Introduction: 
 
In order to meet the needs of our many stakeholders and to deliver timelier data, the 2012 
Massachusetts Death report has a new more compact format. In contrast to recent reports, this 
report contains a brief summary of deaths to Massachusetts residents in 2012. The report also 
includes comparisons to recent years with important trends being noted. The Top 10 Causes of 
Death are summarized in table form. Finally, four special topics have been selected for deeper 
discussion: Disparities, Injuries/Opioid Poisonings, Premature and Amenable Mortality, and 
HIV/AIDS.  
 
The intent of presenting these data in a new format is to make these data available to decision-
makers and the public as quickly as possible. By simplifying the report and focusing on 
highlights, this report and future reports can be delivered more quickly. 
 
This 2012 Massachusetts Death report is targeted to the general public, the legislature, and the 
press. A separate Data Brief (Massachusetts Deaths 2012: Data Brief) has been prepared with 
extensive tables cross-tabbed by cause of death, geography, demographics, and time. The data 
brief is targeted to researchers, academics, and all others who wish to examine a more detailed 
presentation of these data. It includes the bulk of the material contained in previous reports but 
offer little commentary other than the methodologies for computing the statistics presented. 
 
Summary of 2012 Deaths:  
Massachusetts mortality continues to compare favorably with the U.S. and there are continued 
declines in many of the leading causes of death. Most death rates in Massachusetts were lower 
than those of the US including those for heart disease, stroke, chronic lower respiratory disease, 
unintentional injuries, homicide, suicide, Alzheimer’s disease, chronic liver disease, HIV/AIDS, 
infant mortality, and diabetes.  
 
In 2012, the age-adjusted death rate of 669.2 deaths per 100,000, reached another all-time low. 
The rate has been declining at an average of 1.8% per year since 2000. For the third year in a 
row, the death rate for Blacks is not statistically different from the rate of Whites (701.8 vs. 681.0 
deaths per 100,000). The rate for Asians was the lowest for all groups at 372.4 followed by 
Hispanics1 (484.9 deaths per 100,000). 
 
Given the all-time low death rate, it is not surprising that people in Massachusetts are living 
longer than ever before. Life expectancy was also at an all-time high in Massachusetts (80.9 
years) in 2012. A baby girl born in Massachusetts in 2012 could expect to live to be 83, and a 
baby boy could expect to live to be 79 years old. 
                                               
1
 There are well-known difficulties in calculating accurate mortality rates for Massachusetts’ smaller populations such 
as Asians, Native Americans and Hispanics. Arias E. Quality of race and Hispanic origin reporting on death 
certificates in the United States. Presented at the 2004 NCHS Data Users Conference. Washington, DC, July 14, 
2004. Available at: http://www.cdc.gov/nchs/ppt/duc2004/arias.pps. 
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Despite improvements in the death rate for most causes, poisonings (particularly opioid 
poisonings) reached an all time high in 2012. Opioids, including heroin, oxycodone, morphine, 
codeine, and methadone, were associated with the vast majority of poisoning deaths (74%). As 
in past years, falls were the second leading cause of injury deaths. In 2012, the number of fall-
related deaths increased by 9% from 2011 (642 vs. 588). 
 
In 2012, 10% of all deaths and 26% of premature deaths (i.e., deaths to individuals under the 
age of 75) were categorized as “amenable to health care”. In other words, these deaths may 
have been prevented with timely and effective health care. Since 2002, the amenable mortality 
rate has declined 4.1% per year in Massachusetts. For Blacks, the reduction has been 4.9% per 
year. For Hispanics, it is 4.2% per year. For Asians, the rate is 2.7%. The rate for Whites 
declined at 4.8% per year between 2002 and 2008 but has recently slowed to a rate of decline 
of only 2.5% since 2008. 
 
The top 10 causes of death are shown in the table below, with comparisons to the years 2000 
and 2009. As in recent years, cancer is the leading cause of death in terms of absolute numbers 
and also when adjusted for the age of the population. Heart disease is the second leading 
cause of death. Seven of the 10 leading causes of death were lower than in both 2000 and 
2009.  Notable decreases since 2000 are a 35% decrease in the death rate for heart disease 
and a 44% decrease in the death rate for stroke. Also notable is the 56% drop in deaths since 
2000 where HIV or AIDS is listed as the underlying cause of death. In contrast, the death rate 
for injuries of all causes (including opioids and falls) increased by 19% since 2000. 
 
Several factors may account for the generally favorable numbers in Massachusetts. These 
include our high quality health care, higher than average socioeconomics, and high education 
levels compared to other states. Nonetheless, pockets of disparities still persist with higher 
death rates for certain causes of death for some racial groups, for the poor, for those with lower 
levels of education, and for those who live in certain geographical areas. The disparities have 
remained relatively constant in recent years. For detailed information on these disparities, 
please refer to the separate Data Brief (Massachusetts Deaths 2012: Data Brief). 
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Top Ten Causes of Death 
 
 
Leading Causes of Death, MA: 2000, 2009, 2012 
  2000 2009 2012 
Cause Rank 
Number 
of Deaths 
Age 
Adjusted 
rate per 
100,000 
Rank 
Number 
of 
Deaths 
Age 
Adjusted 
rate per 
100,000 
Rank 
Number 
of 
Deaths 
Age 
Adjusted 
rate per 
100,000 
 
Cancer 
 
2 14,006 206.9 1 13,042 174.0 1 12,850 166.7 
 
Heart Disease 
 
1 15,313 218.0 2 12,233 155.0 2 11,586 141.3 
 
All Injuries 
combined 
 
5 2,386 35.9 3 2,920 41.4 3 3,053 42.6 
Chronic Lower 
Respiratory Disease 
 
4 2,911 41.9 5 2,546 33.6 4 2,520 32.3 
 
Stroke 
 
3 3,645 51.2 4 2,552 32.2 5 2,360 28.7 
 
Alzheimer’s Disease 
 
7 1,427 19.7 6 1,690 20.6 6 1,711 20.1 
Influenza & 
Pneumonia 
 
6 2,110 29.3 7 1,335 16.8 7 1,356 16.3 
 
Nephritis 
 
9 1,230 17.6 8 1,267 16.1 8 1,267 15.7 
Ill-defined 
conditions-signs and 
symptoms 
13 490 7.1 11 617 8.2 9 1,120
1
 14.3 
 
Diabetes 
 
8 1,353 19.7 9 995 13.1 10 1098 13.9 
 
1
 This category is often dependent on additional information from the Office of the Chief Medical Examiner.  The 2012 
death file had a higher proportion of such cases than previous years. This may account in part for the increase seen 
in 2012. 
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Special Topics 
 
1. Disparities  
 
Racial and ethnic health disparities in the United States were first documented and reported 
in 1985 in a landmark report issued by U.S. Health and Human Services Secretary, 
Margaret Heckler.  The report identified differences in health outcomes for racial and ethnic 
American populations; differences that result in these populations having poorer health than 
White, non-Hispanic Americans.  Even with significant improvements in health and health 
services over the decades health and healthcare disparities continue to exist and, in some 
cases, continue to grow for racial and ethnic groups, the poor and other at-risk populations. 
(U.S. Office of Minority Health in its National Stakeholder Strategy for Achieving Health 
Equity Report, 2011). 
 
The term health disparities refers to population-specific differences in the presence of 
disease, health outcomes, quality of health care, and access to health care services that 
exist across racial, ethnic, low-income, and other groups.2  
 
Thanks in part to a focus on preventive medicine and advances in medical care and 
technology, Massachusetts residents and Americans as a whole are healthier and living 
longer, however, health and healthcare disparities continue to exist and in some cases even 
to grow. Racial and ethnic groups, the poor and other at-risk populations are most affected.  
 
These disparities are costly in both personal and financial terms. According to a 2009 study 
by the Joint Center for Political and Economic studies, eliminating health disparities for 
minorities would have reduced direct medical care expenditures by $229.4 billion over a 
three-year period. The same study noted that 30.6% of direct medical care expenditures for 
African Americans, Asians, and Hispanics were excess costs due to health inequalities. 
 
These excess costs affect all Americans. Nearly two dollars in every five of excess costs are 
born by private insurance plans. Individuals and families paid another one-quarter in out-of-
pocket payments which is more than Medicare and Medicaid combined.  
 
Though the MA 2012 Death report reveals that, for the third year in a row, the death rate for 
Blacks was not statistically different from the rate of Whites (701.8 vs. 681.0 deaths per 
100,000), Hispanics, Blacks, and Asians had a higher proportion of deaths occurring at 
younger ages than Whites. Thirty-four percent (34%) of White deaths occurred at 74 years 
and younger; whereas, 67% of Hispanic deaths, 59% of Black deaths, and 47% of Asian 
deaths occurred under 75 years of age. 
 
In addition, Blacks and Hispanics continued to be disproportionally affected by homicide: the 
rate for Blacks was 11 times higher than that of Whites, and the homicide rate for Hispanics 
was four times higher. 
 
It is also important to note that this is not “simply” a racial or ethnic problem. Disparities also 
exist by gender, sexual orientation, age, education, income, and geography. 
 
                                               
2
 http://www.ncsl.org/research/health/health-disparities-overview.aspx 
  
   
  
6 
 
According to the 2012 Death report, the death rate for those with a high school education or 
less was more than three times higher than the rate for those with 13 years of education or 
more. The age-adjusted premature mortality rate for those living in areas with the greatest 
poverty (≥ 20% below poverty) was more than four times higher than the rate for those living 
in the most affluent areas (<5% below poverty).  
 
Closing the Gap   
 
The solutions to addressing persistent disparities are complex.  
 
We know that health, quality of life, and longevity are determined by genetic, social, 
behavioral, and environmental factors. The conditions in which we are born, live, learn, age, 
work, play, and receive healthcare all impact wellbeing and years of life lived.  In order to 
improve health disparities, DPH has focused on connecting clinical and community efforts.     
 
In 2012, Massachusetts legislation3 mandated the formation of a Prevention and Wellness 
Trust Fund (PWTF), a program designed to improve health, reduce health care costs, and 
reduce health disparities by addressing chronic health conditions. 
 
The PWTF currently funds nine community-clinical partnerships throughout the 
Commonwealth. Each partnership must implement programs, policy, systems, and 
environmental change strategies in their communities to address priority health conditions: 
pediatric asthma, hypertension, tobacco, and falls among older adults. Grantees are also 
able to address up to five additional chronic health conditions, including substance abuse, 
obesity, diabetes, oral health, and mental health as a co-morbid condition. 
 
Communities funded by the PWTF are some of the most racially and ethnically diverse 
areas in the Commonwealth with high percentages of people living below the federal poverty 
level.  As a group, these communities have a higher than average burden for all priority and 
optional health conditions targeted by PWTF. 
 
Data collected as part of this initiative is used to identify populations at highest risk for 
adverse health outcomes, determine gaps in service, and monitor program effectiveness.  
 
The PWTF focuses on linking clinical and community organizations; creating health-
promoting environments through policy, systems, and environmental change; and 
continuously examines detailed data for evaluation and program improvement. 
 
 
2. Injuries/ Opioid Poisonings: A Public Health Crisis 
 
Poisonings, most of which are drug overdoses, continued to be the leading cause of injury 
deaths in Massachusetts. Opioids, including heroin, oxycodone, morphine, and codeine, are 
the agents most associated with poisoning deaths. 
 
In 2012, 711 Massachusetts residents died from opioid poisoning. This represents an 800% 
increase over the past 25 years, and 10% increase from 2011, when 645 deaths resulted 
                                               
3
  (Chapter 224: An Act Improving the Quality of Health Care and Reducing Costs through Increase Transparency, 
Efficiency and Innovation) 
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from opioid poisoning. This 2011 figure also represents a 16% increase from 2010, when 
555 people died. 
 
Eighty percent of poisoning deaths are unintentional and for every unintentional opioid 
death, it is estimated that there are seven nonfatal opioid events treated in acute care 
hospitals in Massachusetts4. Poisonings took the lives of nearly three times more people in 
the Commonwealth than motor vehicle accidents.  
 
The risk of opioid-related death has increased dramatically for every population group and 
every type of community in the state, affecting Massachusetts residents from every age, 
racial, economic, and geographic group. Opioid poisoning deaths occur in poor urban areas 
and in affluent suburbs. Whites are more likely to die from opioid poisoning than Blacks or 
Hispanics. 
 
Opioids are prescribed to relieve pain from injury, trauma, surgery, chronic pain, and other 
conditions such as cancer. They also affect regions of the brain that produce euphoria and 
can produce significant side effects, including constipation, nausea, mental clouding, and 
respiratory depression, which can sometimes lead to death.  
 
From 1991 to 2009, U.S. prescriptions for opioid analgesics increased almost threefold, to 
more than 200 million5. While these medications are crucial for pain management, their wide 
availability may also result in leftover pills in family medicine cabinets, increasing 
opportunities for abuse. Most abusers report that they were abusing their own medications, 
or they were using medications prescribed to friends and relatives.  
 
When prescription medications become difficult to obtain or too expensive, many users turn 
to heroin as an alternative. Widely available and relatively inexpensive, heroin is a highly 
addictive opiate that acts on the same areas of the brain as prescription opioids. 
Nevertheless, the number of people who die from prescription opioids exceeds the number 
of those who die from heroin and cocaine combined. 
 
Prescription Monitoring Program (PMP) 
 
The Massachusetts Department of Public Health operates a number of programs and 
services designed to prevent and treat opioid poisonings and educate health care providers 
and the general public about this growing problem. Given the dramatic increase in the use of 
prescription opioids, this report will focus on just one - the Massachusetts Prescription 
Monitoring Program (MA PMP). 
 
MA PMP compiles prescription information from all Massachusetts pharmacies and from 
out-of-state mail order pharmacies that deliver to patients in Massachusetts.  The MA Online 
PMP is a secure website that can be utilized by authorized providers to retrieve the most 
recent twelve months’ of dispensed prescription histories (Schedule II - V) on their patients. 
Use of the MA PMP by prescribers can enable the early identification of behaviors 
suggestive of drug misuse, abuse or diversion.  
 
                                               
4
 MA DPH Injury Surveillance Program. 
5
 (Research Letter) Characteristics of Opioid Prescriptions in 2009.  JAMA, April 6, 2011—Vol 305, No. 13: 1299-
1300. 
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As of July 2014, nearly 54,000 prescribers, dispensers, and law enforcement participants 
had been enrolled to use the system. Providers use the PMP as a clinical decision-making 
tool, use it to ensure patient safety, and are able to identify questionable activity by some 
patients that might be demonstrating addictive behaviors.  
 
The Department of Public Health’s Drug Control Program (DCP) analyzes PMP data to 
determine prescribing and dispensing trends. It also provides educational information to 
health care providers and the general public; and case information to regulatory and law 
enforcement agencies. 
 
 
3. Premature and Amenable Mortality  
 
Premature mortality 6 is a measure of unfulfilled life expectancy and is defined as the age 
adjusted death rate for persons under 75 years of age. Premature Mortality (PMR) is 
considered an excellent, single measure of the health status of a population, since the vast 
majority of deaths to persons ages 75 years and older are due to chronic conditions 
associated with aging.  
 
In 2012, premature deaths (deaths before age 75) accounted for 37% of all deaths in the 
state. Overall PMR decreased by 3.1% a year for the period of 2002-2009 and has 
remained stable since then, with no significant changes from 2009 - 2012. 
 
A subset of premature mortality is “amenable mortality” which is defined as deaths that may 
have been prevented with timely and effective health care. Among those deaths included in 
this category are breast, cervical, and skin cancer, as well as bacterial infections, diabetes, 
cardiovascular and cerebrovascular disease, Ischemic heart disease, and complications of 
common surgical procedures7.  
 
Amenable mortality rates have been declining at 4.1% per year since 2002. In 2012, 10% of 
all deaths and 26% of premature deaths were amenable to health care.  
  
These rates have been declining for racial and ethnic groups as well: at 4.9% per year for 
Blacks, 4.2% per year for Hispanics, and 2.7% per year for Asians. The rate for Whites had 
been declining at 4.8% per year for the period of 2002 to 2008 and it is now declining at a 
rate of 2.5% since 2008. Despite these declines, the amenable mortality rate for Blacks is 
1.4 times higher than the rate for Whites (99.2 vs. 70.4) in 2012.  
 
Several studies have found that variations in premature and amenable mortality appear to 
be closely related to socioeconomic conditions8, including environmental conditions, 
housing, education, stress, higher rates of smoking, substance abuse, violence, obesity, and 
lack of access to care.  
 
PMR for those living in areas with the greatest poverty (≥ 20% below poverty) was more 
than 4 times higher than the rate for those living in the most affluent areas (<5% below 
                                               
6
 Carstairs V, Morris R. Deprivation and Health in Scotland. Aberdeen, Scotland: Aberdeen University Press, 1991. 
7
 Nolte E and McKee CM. Measuring the Health of Nations: Updating An Earlier Analysis. Health Affairs; 2008; 27(1): 
58-71. 
8
 Mackenbach JP, Bouvier-Colle MH, Jougla E. “Avoidable” mortality and health services: A review of aggregate data 
studies. J Epidmiol Commun Health 1990;44:106-11. 
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poverty). For amenable mortality, the rate for those living in areas with the greatest poverty 
was 5 times higher than the rate for those living in the most affluent areas.  
 
 
4. HIV/AIDS 
 
At the height of the HIV/AIDS epidemic, transmission of HIV infection was continuing nearly 
unabated, and deaths attributable to HIV/AIDS were nearing 1,000 per year (981 in 1994.) 
Since that time, the combination of advances in medical treatment, public policy, improved 
access to care, and ongoing education have resulted in tremendous progress.  
 
Massachusetts has seen steady declines in HIV transmission (a 44% reduction in new 
diagnoses of HIV infection between 2000 and 2010). Death rates from HIV/AIDS have also 
dropped substantially. In 2012, 100 deaths listed HIV or AIDS (or an AIDS-defining 
condition) as an underlying cause of death. This represents a 56% reduction since 2000.  
 
Deaths among persons with HIV/AIDS (all causes) in 2012 totaled 208, making HIV/AIDS 
the cause of death for only 48% of all deaths among this population. In other words, persons 
with HIV/AIDS who have recently died are more likely to have had a non-HIV/AIDS-related 
cause of death. In the early days of the HIV/AIDS epidemic, deaths among younger 
individuals with HIV/AIDS were common; in 2012, only 18% of HIV/AIDS-attributed deaths 
occurred among persons under the age of 45. 
 
The pattern of deaths among persons with HIV/AIDS now begins to resemble those of older 
population and individuals with other behavioral risk factors.  
 
Medical Advances in Treatment 
 
Prior to 1997 and the advent of highly active antiretroviral therapy (HAART), a combination 
of conditions commonly resulted in severe illness and death among persons with HIV/AIDS. 
Due to a HIV’s ability to compromise the immune system, a range of opportunistic bacterial, 
viral, and fungal infections, cancers, as well as HIV-related wasting often resulted in life-
limiting illness. While medications for HIV infection became available as early as 1986 with 
the introduction of AZT and other classes of anti-HIV medications, it was an era of 
combination therapy--the use of multiple classes of medications to reduce viral replication--
that began to alter the rate of death related to HIV infection. 
 
These medical advances shifted the focus of programs sponsored by federal, state, and 
local public health authorities. With effective treatments available, it became more urgent to 
help all persons living with HIV to learn of their infection status and enter sustained medical 
care. Existing outreach and behavioral prevention programs added routine HIV screening 
activities, and supported referrals to care to their service mix. Case managers, who 
previously spent a great deal of their time assisting their clients to meet basic needs and 
often planning for end-of-life care, shifted to a greater health system navigation role. Medical 
case management became a larger component of the Department’s funded service system, 
consisting of nurse managers helping to coordinate patients’ complex primary and specialty 
care to maximize medical benefits. Prior investments in short-term hospice care shifted to 
coordinated approaches to supporting the housing and social service needs of persons with 
HIV/AIDS, who were now looking at extended lifespans. 
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Public Policy 
 
A series of public policy advances in Massachusetts during the last decade helped 
maximize the benefits of improved treatments for HIV/AIDS.  
 
The cost of HAART combination therapies could range into the tens of thousands of dollars 
per year, and uninsured individuals were especially challenged to find the means to access 
them. Federal Medicaid rules limited coverage for single childless individuals to those with 
severe disabilities, in these instances, to a diagnosis of AIDS. Low-income individuals could 
not receive Medicaid coverage for their medical care until they were severely ill with AIDS.  
 
In 2001, through an 1115 waiver from the federal CMS, Massachusetts became the first 
state in the nation to successfully expand its Medicaid coverage to persons with non-AIDS 
HIV infection meeting certain income requirements (<200% FPL). This change in policy 
greatly expanded access to HAART.  
 
With the passage of state health reform legislation in 2006, an even larger proportion of 
persons with HIV obtained health insurance. This was especially significant for those 
earning 201-300% FPL and eligible for subsidized coverage.  
 
The state HIV Drug Assistance Program (HDAP) shifted its approach from the direct 
purchase of medications to the more cost-effective supplementing of health insurance 
premiums and medication co-payments. This ensured access to comprehensive HIV care 
for more patients. Coupled with long-term investments in building the HIV care system at 
community health centers and other safety-net health institutions, Massachusetts became 
the first state to essentially guarantee access to HAART for all residents living with HIV 
infection. 
 
It is now well documented in the literature that effective suppression of HIV viral loads 
(helping patients achieve undetectable levels of HIV in their blood) has a direct impact on 
the likelihood of viral transmission. Since 2000, Massachusetts has documented steady 
declines in new HIV diagnoses, even as the Commonwealth greatly expanded testing and 
screening for HIV infection.  
 
People with HIV/AIDS in Massachusetts are now benefitting from access to comprehensive 
services such as infectious disease testing and screening, effective medications, and a 
range of supportive services. These factors, coupled with near-universal health insurance 
access, are enabling people with HIV/AIDS to maintain health and have a reasonable 
expectation of a normal life span. 
 
Maintaining the state HIV/AIDS prevention and care system remains a high priority if these 
gains are to be sustained or improved upon in the future. 
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Summary 
 
 
Massachusetts mortality continues to compare favorably with the U.S.  In 2012, declines 
continued for most major causes of death. Cancer continues to be the leading cause of 
death in Massachusetts.  For the third year in a row, the death rate for Blacks was not 
statistically different from the rate of Whites, however disparities in mortality continue to exist 
among racial, economic, and other groups. Given the all-time low death rate, it is not 
surprising that people in Massachusetts are living longer than ever before. 
 
The death rate for unintentional poisonings (particularly opioid poisonings) reached an all 
time high in 2012. The number of falls-related deaths also increased by 9% from 2011. 
 
Any single measure of mortality has limitations. However by examining these data, it is 
possible to identify issues that are responsive to systematic public health approaches to 
health promotion and disease prevention. 
 
For more detailed information on 2012 deaths in Massachusetts, please refer to 
Massachusetts Deaths 2012: Data Brief. 
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